Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs โ endorsement.
We have moved...
We have decided to take a break from X, but we want to keep talking about medicines and public & animal health with all of our followers.
Find us on Bluesky โก๏ธ EMA-EU.bsky.social
#JustPublished:
The Chinese CDC has reported a sharp increase in respiratory viral infections, including #hMPV infections.
Based on the current information, ECDC considers that the current situation does not pose any specific concern for the EU/EEA.
ecdc.europa.eu/en/news-eventsโฆ
Join us for another โConversations on Cancerโ session, as we mark #CervicalCancerAwarenessMonth.
๐ January 14, 16:00-17:00 CET | 10:00-11:00 AM ET
๐Registration: europa.eu/!xRd8xC
Every year, 300,000 children face cancer. While survival rates are up to 85%, disparities remain. EMA is committed to advancing treatments with targeted therapies, better clinical trials, and global partnerships.
โ๏ธMay your holidays be filled with health and well-being. Let's look forward to a new year of advances in science and medicines.
#HappyNewYear#EMAHolidayWish#HealthFirst
EMA and HMA updated their guidance for identifying and disclosing confidential information and personal data in marketing authorisation application of medicinesโก๏ธeuropa.eu/!tMrtgD
This ensures transparency when disclosing information to the public on authorised medicines.
Our Executive Director, Emer Cooke, takes stock of EMA's 2024 achievements.
This is the first year EMA issued more than 100 positive opinions for a marketing authorisation since 2009.
Read the full end-of-year message: ema.europa.eu/en/news/emer-cโฆ#EU#PublicHealth
๐ฃAttention clinical trials sponsors!
New year will come with important changes: 30 Jan 2025 marks the end of the transition period to the new Clinical Trials Regulation (CTR).
Ensure your compliance:
๐ europa.eu/!PX9fPm#HealthUnion
New report outlines next steps towards use of electronic product information in the #EU!
This will allow patients and prescribers to access vital, up-to-date information on their medicines more quickly and easily ๐ป
Learn more: ema.europa.eu/en/news/succesโฆ#digitalhealth
๐ข EMA recommends 17 new medicines ๐ for approval:
โ๏ธ 1st medicine to treat #vonHippel-Lindau disease
โ๏ธ 1st treatment for for #PeripheralThyrotoxicosis in patients with Allan-Herndon-Dudley syndrome
โ๏ธ 2 medicines to treat #cancer
๐europa.eu/!gg9d6y